Abiopharma

🔍 Morano Susan E (Director)

Company: BOSTON SCIENTIFIC CORP (BSX)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 3,800 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,463.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,281 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,744.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.
• F2: Grant of restricted stock in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of approximately $72,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000 and committee chair retainer having a value of $20,000) divided by the closing price of the common stock on the date of grant.